July 5, 2011 Schedule 13DA

     PDF provided as courtesy

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)*

Tiger X Medical, Inc.
 (Name of Issuer)

Common Stock, $0.001 par value
 (Title of Class of Securities)

18682E304
 (CUSIP Number)

Eric Honick, Esq.
McLaughlin & Stern, LLP
260 Madison Avenue
New York, New York 10016
(212) 488-1100
 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

July 1, 2011
 (Date of Event which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), (g) or (g), check the following box ¨.

Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosure provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No.

 

18682E304

 

 

 

 

    

  

 

 

 

 

 

1

 

NAMES OF REPORTING PERSONS

Mikhail Kvitnitsky

 

 

 

 

 

 

2

 

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

(a)   ¨ 

 

(b)   ¨ 

 

 

 

3

 

SEC USE ONLY

 

 

 

 

 

 

 

4

 

SOURCE OF FUNDS (See Instructions)

 

 
 

 None.

 

 

 

5

 

CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

 

 

 

¨

 

 

 

6

 

CITIZENSHIP OR PLACE OF ORGANIZATION

 

 

 

United States

 

 

 

 

 

7

 

SOLE VOTING POWER

 

 

 

NUMBER OF

 

None (Item 5)

 

 

 

 

SHARES

8

 

SHARED VOTING POWER

BENEFICIALLY

 

 

OWNED BY

 

None

 

 

 

 

EACH

9

 

SOLE DISPOSITIVE POWER

REPORTING

 

 

PERSON

 

None (Item 5)

 

 

 

 

WITH

10

 

SHARED DISPOSITIVE POWER

 

 

 

 

None

 

 

 

11

 

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

 

 

None (Item 5)

 

 

 

12

 

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

 

 

¨

 

 

 

13

 

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

 

 

0%

 

 

 

14

 

TYPE OF REPORTING PERSON

 

 

 

IN

This Amendment No. 1 amends the statement on Schedule 13D filed with the Securities and Exchange Commission on September 8, 2008 by Mikhail Kvitnitsky ("Reporting Person") with respect to shares of common stock of Tiger X Medical, Inc. f/k/a clickNsettle.com.

Item 1. Security and Issuer

Item 1 is hereby amended, in pertinent part, as follows:

This statement relates to the common stock, par value $0.001 per share (the "Common Stock"), of Tiger X Medical, Inc., a Delaware corporation (the "Issuer"). The Issuer's principal executive offices are located at 7625 Hayvenhurst Avenue, Suite #49, Van Nuys, California 91406.

Item 5. Interest in Securities of the Issuer

Item 5 is hereby amended, in pertinent part, as follows:

 

(a), (b) (c)

  

On July 1, 2011, the Reporting Person disposed of 28,916,654 shares of the Issuer's Common Stock for $2,024,165.78, or $0.07 per share, comprising all of his shares of the Issuer's Common Stock, pursuant to a private sale. Accordingly, as of the date of the filing of this statement, the Reporting Person no longer beneficially owns any shares of the Issuer's Common Stock.

 

      

 

(e)

 

The Reporting Person ceased to be a beneficial owner of 5% or more of the Issuer's Common Stock on July 1, 2011.

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

 

 

 

 

 

 

     Dated: July 5, 2011 

/s/ Mikhail Kvitnitsky  

 

 

Mikhail Kvitnitsky